From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

BACKGROUNDS: Based on in vitro data and results of a recent drug repositioning study, some medications approved by the FDA for the treatment of various non-malignant disorders were demonstrated to have anti-SCLC activity in preclinical models. The aim of our study is to confirm whether use of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohinai, Zoltan, Dome, Peter, Szilagyi, Zsuzsa, Ostoros, Gyula, Moldvay, Judit, Hegedus, Balazs, Dome, Balazs, Weiss, Glen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703211/
https://www.ncbi.nlm.nih.gov/pubmed/26735301
http://dx.doi.org/10.1371/journal.pone.0144797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703211/
https://www.ncbi.nlm.nih.gov/pubmed/26735301
http://dx.doi.org/10.1371/journal.pone.0144797

Ejemplares similares